Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction-Reference-Cited by-同舟云学术

Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction

Published:2021-08 Issue:34 Volume:39 Page:4856-4863
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Shilling Hannah,Garland Suzanne M.,Atchison Steph^ORCID,Cornall Alyssa M.,Brotherton Julia M.L.,Bateson Deborah^ORCID,McNamee Kathleen,Kaldor John M.,Hocking Jane S.,Chen Marcus Y.^ORCID,Fairley Christopher K.,McNulty Anna,Bell Charlotte,Marshall Lewis,Ooi Catriona,Skinner S. Rachel,Murray Gerald^ORCID,Molano Monica,Tabrizi Sepehr,Machalek Dorothy A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

2. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine;Garland;J Infect Dis,2009

3. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey;Brotherton;Vaccine.,2014

4. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach;Brotherton;The Medical journal of Australia.,2013

5. Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination;Machalek;J Infect Dis,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Impact of Knowledge about the Human Papillomavirus and Its Vaccine on Perceived Benefits and Barriers to Human Papillomavirus Vaccination among Adults in the Western Region of Saudi Arabia;Healthcare;2024-07-20

2. Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China;Vaccines;2024-04-12

3. The durability of vaccine-induced protection: an overview;Expert Review of Vaccines;2024-03-20

4. Development of a touchdown droplet digital PCR assay for the detection and quantitation of human papillomavirus 16 and 18 from self-collected anal samples;Microbiology Spectrum;2023-12-12

5. Knowledge, attitudes and acceptance toward Human papillomavirus (HPV) vaccination: Perspectives of Muslim women and men;Vaccine;2023-03